Join
Live feed
·
INSIDERFilingvia Quantisnow
Crinetics Pharmaceuticals Inc. logo

SEC Form 5: Knight Jeff E. acquired $8,141 worth of shares (537 units at $15.16), increasing direct ownership by 11% to 5,487 units

ByQuantisnow·Wall Street's wire, on your screen.
CRNX· Crinetics Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CRNX (Crinetics Pharmaceuticals Inc.) and more on Quantisnow.